Whanin Pharm환인제약
016580 · KOSPI · ₩016580 · 환인제약
₩10,400▼ ₩80 (0.76%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Oct 29, 2026Open on DART
Predicted impact: Medium
Preliminary consolidated results with no figures given; no earlier items to compare against.
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 13, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Jul 29, 2026Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시May 29, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 13, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)May 11, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Apr 27, 2026Open on DART
- Corporate value-up plan기업가치제고계획(자율공시)Mar 23, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 20, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 20, 2026Open on DART
- Audit report submitted감사보고서제출Mar 12, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 12, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 4, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Mar 3, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 3, 2026Open on DART
- Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Feb 13, 2026Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Jan 30, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Dec 22, 2025Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Dec 18, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Dec 15, 2025Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Dec 11, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 13, 2025Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Oct 31, 2025Open on DART
- Change of largest shareholder최대주주변경Oct 30, 2025Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서(최대주주변경시)Oct 30, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 30, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 30, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 30, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Oct 1, 2025Open on DART
- Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Sep 29, 2025Open on DART
- Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Sep 29, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 13, 2025Open on DART
- Amended: Annual report (Dec 2024)[기재정정]사업보고서 (2024.12)Aug 13, 2025Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Aug 1, 2025Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Jul 11, 2025Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Jul 7, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 14, 2025Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Apr 30, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 21, 2025Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 21, 2025Open on DART
- Audit report submitted감사보고서제출Mar 13, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 13, 2025Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 5, 2025Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 5, 2025Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 28, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Feb 28, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Feb 19, 2025Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Feb 17, 2025Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Feb 3, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Whanin Pharm / 환인제약 / 016580 / KRX:016580
Source: KRX statistical information